New Key Statistics Module, Z-Score and F-Score
NSE:JUBLPHARMA Key Ratios
Market Cap ₹ M | 113,901.68 |
Enterprise Value ₹ M | 138,499.68 |
P/E(ttm) | 148.31 |
PE Ratio without NRI | 63.83 |
Forward PE Ratio | -- |
Price/Book | 2.10 |
Price/Sales | 1.72 |
Price/Free Cash Flow | 155.05 |
Price/Owner Earnings | 100.88 |
Payout Ratio % | 0.44 |
Revenue (TTM) ₹ M | 66,448.00 |
EPS (TTM) ₹ | 4.85 |
Beneish M-Score | -2.81 |
10-y EBITDA Growth Rate % | 0.80 |
5-y EBITDA Growth Rate % | -14.80 |
y-y EBITDA Growth Rate % | 7.50 |
EV-to-EBIT | 31.28 |
EV-to-EBITDA | 16.79 |
PEG | -- |
Shares Outstanding M | 158.35 |
Net Margin (%) | 1.16 |
Operating Margin % | 7.81 |
Pre-tax Margin (%) | 2.57 |
Quick Ratio | 1.37 |
Current Ratio | 2.05 |
ROA % (ttm) | 0.68 |
ROE % (ttm) | 1.42 |
ROIC % (ttm) | 2.40 |
Dividend Yield % | 0.69 |
Altman Z-Score | 2.02 |
NSE:JUBLPHARMA Number of Guru Trades
NSE:JUBLPHARMA Volume of Guru Trades
Gurus Latest Trades with NSE:JUBLPHARMA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NSE:JUBLPHARMA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data